Harnessing real-world evidence to reduce the burden of noncommunicable disease: health information technology and innovation to generate insights.

Zou, Kelly H; Li, Jim Z; Salem, Lobna A; Imperato, Joseph; Edwards, Jon; Ray, Amrit

Zou, Kelly H; Li, Jim Z; Salem, Lobna A; Imperato, Joseph; Edwards, Jon; Ray, Amrit.

Afiliación

Zou KH; Research, Development and Medical, Upjohn Division, Pfizer Inc, 235 East 42nd Street, MS 235-9-1, New York, NY 10017 USA.
Li JZ; Research, Development and Medical, Upjohn Division, Pfizer Inc, 10777 Science Center Drive, San Diego, CA 92121 USA.
Salem LA; Research, Development and Medical, Upjohn Division, Pfizer Inc, 235 East 42nd Street, MS 235-9-1, New York, NY 10017 USA.
Imperato J; Research, Development and Medical, Upjohn Division, Pfizer Inc, 235 East 42nd Street, MS 235-9-1, New York, NY 10017 USA.
Edwards J; Envision Pharma Group, Envision House, 5 North Street, Horsham, RH12 1XQ UK.
Ray A; Research, Development and Medical, Upjohn Division, Pfizer Inc, 500 Arcola Road, Collegeville, PA 19426 USA.

Health Serv Outcomes Res Methodol ; 21(1): 8-20, 2021.

Article en En | MEDLINE | ID: mdl-33173407

Palabras clave

Data science; Disease burden; Health information technology; Noncommunicable disease; Population health; Real-world data; Real-world evidence; Risk factors

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies / Screening_studies Aspecto: Ethics Idioma: En Revista: Health Serv Outcomes Res Methodol Año: 2021 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google